• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过羰基还原酶催化还原酶法合成3-取代-4-羟基哌啶的四种立体异构体

Enzymatic synthesis of four stereoisomers of 3-substituted-4-hydroxypiperidines by carbonyl reductase-catalyzed reduction.

作者信息

Chen Jing, Chen Xi, Song Jinsong, Zhang Hongliu, Yang Hongjiang, Feng Jinhui, Wu Qiaqing, Zhu Dunming

机构信息

School of Biotechnology, Tianjin University of Science and Technology Tianjin 300457 China.

Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China

出版信息

RSC Adv. 2025 Jun 26;15(26):21133-21141. doi: 10.1039/d5ra02485d. eCollection 2025 Jun 16.

DOI:10.1039/d5ra02485d
PMID:40575331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12198953/
Abstract

Chiral 3-substituted-4-hydroxypiperidines are highly valuable in pharmaceutical applications due to their diverse and potent biological activities. Biocatalytic ketone reduction by carbonyl reductases represents a promising approach for synthesizing these compounds. In this study, two structurally similar yet stereoselectively distinct carbonyl reductases, HeCR and DbCR, were identified. Both enzymes exhibited exceptional catalytic performance, with >99% enantiomeric excess (ee) and >99% conversion rate in the reduction of -butyl 4-oxo-3-phenylpiperidine-1-carboxylate (1a). We found that 1a exhibits a relatively low rate of racemization under the mild reaction conditions. Subsequently, analogs of 1a were synthesized and reduced with high enantioselectivity (ee > 99%) using HeCR and DbCR. Carbonyl reductases demonstrated excellent catalytic activity and stereoselectivity in the synthesis of 3-substituted-4-hydroxypiperidines with dual chiral centers, underscoring their potential for pharmaceutical applications.

摘要

手性3-取代-4-羟基哌啶因其多样且强大的生物活性在药物应用中具有很高的价值。通过羰基还原酶进行生物催化酮还原是合成这些化合物的一种有前景的方法。在本研究中,鉴定出了两种结构相似但立体选择性不同的羰基还原酶,即HeCR和DbCR。在还原4-氧代-3-苯基哌啶-1-羧酸叔丁酯(1a)时,这两种酶均表现出卓越的催化性能,对映体过量(ee)>99%且转化率>99%。我们发现1a在温和反应条件下的外消旋化速率相对较低。随后,合成了1a的类似物,并使用HeCR和DbCR以高对映选择性(ee>99%)进行还原。羰基还原酶在合成具有双 chiral 中心的3-取代-4-羟基哌啶时表现出优异的催化活性和立体选择性,突显了它们在药物应用中的潜力。 (注:原文中“chiral”重复出现,推测可能有误,这里保留原文进行翻译)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a323/12198953/c64bfb12f680/d5ra02485d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a323/12198953/753e59e1f2ba/d5ra02485d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a323/12198953/c64bfb12f680/d5ra02485d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a323/12198953/753e59e1f2ba/d5ra02485d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a323/12198953/c64bfb12f680/d5ra02485d-f2.jpg

相似文献

1
Enzymatic synthesis of four stereoisomers of 3-substituted-4-hydroxypiperidines by carbonyl reductase-catalyzed reduction.通过羰基还原酶催化还原酶法合成3-取代-4-羟基哌啶的四种立体异构体
RSC Adv. 2025 Jun 26;15(26):21133-21141. doi: 10.1039/d5ra02485d. eCollection 2025 Jun 16.
2
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.免疫调节剂和免疫抑制剂治疗复发缓解型多发性硬化症的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD011381. doi: 10.1002/14651858.CD011381.pub3.
3
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.用于多发性硬化症的免疫调节剂和免疫抑制剂:一项网状Meta分析
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD008933. doi: 10.1002/14651858.CD008933.pub2.
6
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
7
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
8
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.对首次出现提示多发性硬化症临床发作的患者使用疾病修饰药物进行治疗。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
9
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
10
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.用于复发缓解型多发性硬化症的免疫调节剂和免疫抑制剂:一项网状荟萃分析。
Cochrane Database Syst Rev. 2015 Sep 18;2015(9):CD011381. doi: 10.1002/14651858.CD011381.pub2.

本文引用的文献

1
Easy and accurate protein structure prediction using ColabFold.使用ColabFold进行简单而准确的蛋白质结构预测。
Nat Protoc. 2025 Mar;20(3):620-642. doi: 10.1038/s41596-024-01060-5. Epub 2024 Oct 14.
2
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure.BMS-986308 的发现:一种用于心力衰竭治疗的肾脏外髓质钾通道抑制剂。
J Med Chem. 2024 Jun 13;67(11):9731-9744. doi: 10.1021/acs.jmedchem.4c00893. Epub 2024 May 29.
3
Semirational Engineering of a Thermostable Carbonyl Reductase for the Precision Synthesis of (2,3)-2-Methyl-2-benzyl-3-hydroxycyclopentanone and Its Analogues.
理性设计耐热羰基还原酶用于(2,3)-2-甲基-2-苄基-3-羟基环戊酮及其类似物的精准合成。
J Org Chem. 2023 Aug 18;88(16):11905-11912. doi: 10.1021/acs.joc.3c01192. Epub 2023 Aug 1.
4
Incretin Analogs for Weight Management in Adults Without Diabetes.用于管理无糖尿病成人体重的肠降血糖素类似物。
Ann Pharmacother. 2024 Apr;58(4):398-406. doi: 10.1177/10600280231190089. Epub 2023 Jul 31.
5
Enzymatic synthesis of enantiopure alcohols: current state and perspectives.对映体纯醇的酶促合成:现状与展望
RSC Adv. 2019 Jan 15;9(4):2102-2115. doi: 10.1039/c8ra09004a. eCollection 2019 Jan 14.
6
Biocatalysis making waves in organic chemistry.生物催化在有机化学中掀起波澜。
Chem Soc Rev. 2022 Jan 24;51(2):594-627. doi: 10.1039/d1cs00100k.
7
Green Chemistry in the Synthesis of Pharmaceuticals.药物合成中的绿色化学
Chem Rev. 2022 Feb 9;122(3):3637-3710. doi: 10.1021/acs.chemrev.1c00631. Epub 2021 Dec 15.
8
New Trends and Future Opportunities in the Enzymatic Formation of C-C, C-N, and C-O bonds.新型酶法在 C-C、C-N 和 C-O 键形成中的趋势和未来机遇。
Chembiochem. 2022 Mar 18;23(6):e202100464. doi: 10.1002/cbic.202100464. Epub 2021 Nov 24.
9
Identification of aryl sulfonamides as novel and potent inhibitors of Na1.5.鉴定芳基磺酰胺类化合物为新型强效钠离子通道 1.5 型抑制剂。
Bioorg Med Chem Lett. 2021 Aug 1;45:128133. doi: 10.1016/j.bmcl.2021.128133. Epub 2021 May 24.
10
Biocatalysis: Enzymatic Synthesis for Industrial Applications.生物催化:工业应用中的酶法合成。
Angew Chem Int Ed Engl. 2021 Jan 4;60(1):88-119. doi: 10.1002/anie.202006648. Epub 2020 Aug 17.